Supplementary Data from Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Methods; Supplementary Table S1.
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362426343
